Amarin Corporation plc (NASDAQ:AMRN)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for AMRN
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- Max115: $AMRN Moving, can it continue?
- Max115: $AMRN Anyone follow this one?
- scottrades: Still a big week for #Earnings. Make sure and check those dates! $BABA $PZZA $GOLD $TA $AMRN $CRON $GOOS and lots of others.
- tartan: @scottrades $PYPL $SQ $BABA $CLX $ROKU $W $PTON $QCOM $WING $SWKS $CVS $GOLD $NET $SPCE $GM $HZNP $LL $MPC $AZN $WM $TTD $EL $DBX $AYX $ON $ZNGA $CWH $AMCX $MELI $SEDG $REGN $CPE $LDOS $AMRN $UBER $BMY $KPTI $LITE $HUM $WEN $BHC $MCK $CPLP Always appreciate a heads up on earnings I think $BILL is due to report this week also
- scottrades: Some Earnings to be aware of this week. $PYPL $SQ $BABA $CLX $ROKU $W $PTON $QCOM $WING $SWKS $CVS $GOLD $NET $SPCE $GM $HZNP $LL $MPC $AZN $WM $TTD $EL $DBX $AYX $ON $ZNGA $CWH $AMCX $MELI $SEDG $REGN $CPE $LDOS $AMRN $UBER $BMY $KPTI $LITE $HUM $WEN $BHC $MCK $CPLP
- Max115: $AMRN Did they lose the patent case?
- mogo: I’ve been waiting forever for $AMRN to break out! Is today finally the day?
- SADL: $AMRN Breaking out of a multi months squeeze
- Herb: @SADL $AMRN earnings were this morning.
- ikkyu000: @scottrades $CLX $BYND $SQ $MRNA $ROKU $FSLY $TSN $ATVI $CHGG $CVS $W $DIS $MELI $GPN $SPCE $TWLO $CMS $LVGO $MCK $AMRN $ETSY $PLUG $NET $BMY $RACE $TTWO $MPC $MPLX $ZNGA $DBX $DDOG $UBER $WIX $KOS $TTD $ENPH $CRON $BP $TEVA $PENN $FVRR $RNG #Earnings Thanks so much for the list. If you could post a list every week during earnings season, that would be great. I plug the symbols into a watchlist to watch for intraday snap-back reversals (my favorite kind of trade).
- scottrades: Some #Earnings to be aware of next week. $CLX $BYND $SQ $MRNA $ROKU $FSLY $TSN $ATVI $CHGG $CVS $W $DIS $MELI $GPN $SPCE $TWLO $CMS $LVGO $MCK $AMRN $ETSY $PLUG $NET $BMY $RACE $TTWO $MPC $MPLX $ZNGA $DBX $DDOG $UBER $WIX $KOS $TTD $ENPH $CRON $BP $TEVA $PENN $FVRR $RNG
- mogo: $AMRN Getting close to breaking out.
- mogo: $AMRN has been squeezing since the end of April. Taking an early entry at the bottom of a tight range now. Pretty safe with a stop below range (2.5% max loss).
- Trendrider: $amrn squeezing
- Max115: $AMRN @ Scottrades What are your thoughts on this puupy,finally above the 50d and squezzing?
- shoredriver: $AMRN...down another 10% in pre due to FDA ruling of competitors generic....likely going much lower....thankfully np.......
- Max115: $AMRN Approaching the upper bb
- veghead: $AMRN moving nicely. Volume picking up.
- cheeks: @Herb $AMRN $APT I kept too tight of a stop and was stopped out and had to leave my desk by 11.. you win some you lose some
- SlimChance: $AMRN on move, adding
- RKhan: $AMRN a good buy ?
- skategirl: $AMRN nice hold from yesterday...thanks , Dan
- RKhan: What is good price for $AMRN ?
- DAN: This is a post I just made in our trading forum. Here's the gist of it: We have been making a ton of money over the past couple of days on stocks like $APT $LAKE $LK $AMRN and $DOCU. These stocks have been extremely volatile, but experienced trader ...
- Seemaaziz: @DAN $APT $LAKE $LK $AMRN $DOCU #59MT , will be buying this today and learning it over the weekend.
- Jazman0013: @DAN $APT $LAKE $LK $AMRN $DOCU #59MT awesome. Never forget the first time it was available. Vegas, great course. Has done well for me when I am available to the morning action. Wish I was every day...
- jlutzkanin: @DAN $APT $LAKE $LK $AMRN $DOCU #59MT Just signed up today. Looking forward to learning over the weekend.
- Ruthboone: @DAN $APT $LAKE $LK $AMRN $DOCU #59MT I have been trading for a while. Mostly by reading a lot about companies and knowing certain companies well. I have built up my portfolio slowly and am soaking up all this new knowledge . Would the course benefit someone like me that’s really a newbie to all of this learning ? Or is this more beneficial to seasoned traders
- Trendrider: $amrn Can you talk about this for a potential snap back?
- ebutt841: @Trendrider $amrn Agreed!!
- phgruver: @Trendrider $amrn No, not likely. Basically, a Nevada court -- well, they didn't actually invalidate their patent, but they did say that anyone who wants to can duplicate their product without paying royalties. While they have pledged to appeal, it will probably prove to be too expensive. @Dan just covered $AMRN, and his opinion is a bit different. His trade, set a stop at $3.98, and see where it goes.
- CraigReynolds: @phgruver $amrn $AMRN Not sure Dan was aware of news, most important.
- phgruver: @CraigReynolds $amrn $AMRN He was aware that it was an adverse patent ruling. What he's looking for is a day trade. Just a few percentage points....
- CraigReynolds: @phgruver $amrn $AMRN Yes, believe for a short term trade, he was looking at chart.
- Trendrider: $amrn above vwap
- Brice: Picked up $AMRN and $APT in this morning's Trade the Open. Thanksaolt!
- scottrades: @Brice $AMRN AMRN is going crazy right now!
- scottrades: @scottrades $AMRN Consider moving your stops up on this now.
- Cheezit: @Brice $AMRN $APT Sold 25% of position on APT for a 12% gain, moved the rest above break even with stops. Will look to dump a bit more if it pops again. Then just leave 50% sit above break even.
- Brice: @scottrades $AMRN Stop raised to R2 or 4.51
- geebo: @scottrades $AMRN Is there any way to have a price target on a move like this?
- Trendrider: $amrn was doing a little research on amrn. analysts are still keeping their price targets. theres a chance that they get the verdict overturned.
- Herb: $AMRN Amarin coming off session highs; hearing Jefferies analyst M. Yee out earlier, after speaking with IP attorney, suggested AMRN will likely win an appeal; up a hefty 16.5% on the day now (4.65 +0.65)
- scottrades: @geebo $AMRN It's hard because this is a news event not a technical setup. That said, I would look for more on a strong close today.
- cheeks: anyone else buy $AMRN instead of $APT and are planning on crying themselves to sleep tonight??
- Herb: @cheeks $AMRN $APT Up 24.5% is not chopped liver. . . . .
- Herb: @shoredriver $amrn He's obviously seriously disappointed. I'm waiting to hear more from him. Here's what the company says: https://finance.yahoo.com/news/amarin-comments-ruling-vascepa-anda-222532146.html
- Herb: It's not a level playing field. Today, Jeffries downgraded $AMRN and reduced their target from 30 to 4. If that doesn't lock down a xmas bonus, I don't know what would. . . . .
- wijimmy: @Herb $AMRN ... All over FISH OIL ??? The court ruling will be appealed and this could be a over reaction/over correction ...could be one to watch..
- Herb: @wijimmy $AMRN I think it is difficult to purify the oil to the degree that they do. Evidently the degree of purification is quite important. This is not what you buy at the health food store, evidently.
- shoredriver: $AMRN......np....thankfully...down 62% after hours......
-
DAN: ...
$AMRN -- unfavorable patent ruling. Only 60% down.
$INO -- Gap 11%. Down 13% from the high. Down 3.61% on the day.
$RHHBY -- Roche Pharma. Tocilizumab to treat C19. Watch for breakout above $50-day MA.
$ABT -- Gap and crap.
TELECONFERENCE/WORK-A ... - kshaggy456: $amrn what should we do with puke fest
- Herb: @kshaggy456 $amrn What a wipeout!
- kshaggy456: @kshaggy456 $amrn this drug needed because doctors can’t prescribe fish oil for your heart because it’s not fda approved so if this is not fda approved doctors won’t prescribe something like this but something that has 12 side effects and could kill you or make you bald
- shoredriver: @Herb $amrn ...what does your Kiwi pal say now??
- shoredriver: $AMRN......pos......np
-
Brice: ...
"$AMRN $AYI I got to the session about 20 minutes late, but time was perfect for
watching these two stocks. I entered $AMRN at 10:12 and AYI at 10:22 after intra day
consolidation and just before their moves higher. Out of both around 10:51 wit ... - Herb: $AMRN AMRN Amarin moving higher after insurer Cigna (CI) adds coverage of Vascepa (21.36 +0.35). np
- Herb: $AMRN from my guy: Lot of analysis over the weekend on why Amarin will win the patent case. Analysis from attorneys and others. Generics have to provide “ clear and convincing evidence “ ... just not “ above reasonable doubt “. High bar.
- Herb: @bsnceo $AMRN I suspect so.
- PJMR11: $AMRN. Up significantly in pre-market. Couldn’t find any news that would explain this move. Anyone have information on this move?
- BocaRick: @PJMR11 $AMRN received positive news on their drug trial, also, upgraded by Cantor Fitzgerald. News on #TWTR, both $ACST and $AZN have stopped their trials on a similar(?) #CV drug? Up in early trading, but low volume?
- PJMR11: @BocaRick $AMRN $ACST $AZN #TWTR #CV thanks
- Herb: $AMRN from my kiwi friend: Amarin. This patent trial is a huge deal. If AMRN prevails then entire “ fish oil “ medicine sector will be theirs. The other fish oil drug Lovaza .. still prescribed ... does not work to reduce risk of heart attack and stroke AZN trial used a very similar “ fish oil “ Generic and AMRN could not settle so the trial started at 8.30 am today Baker Bros own 41m shares and have not sold any recently. .. but I watch their SEC disclosure filings every day Trial failed and AZN stopped the Strength trial with similar fish oil Only Amarins Vascepa works. Stock will jump IF they can win the patent trial started today
- bsnceo: @Herb $AMRN may I assume that $AMRN is the plaintiff?
- Herb: $AMRN The AZN trial was an Outcome trial like Amarins Reduce it Trial They spent over $100m enrolled 12,000 etc
- GOOSE: Weekly Expirations: $RAD 1/10/20 13.0 CALLS $LK 1/10/20 40.0 CALLS $AMD 1/10/20 48.0 PUTS $ I " " 7.0 PUTS $ I 1/10/20 7.5 PUTS $ I " " 8.0 CALLS $AMRN 1/10/20 22.0 CALLS $STNE " " 39.0 CALLS STOCK CALLED $NTNX " " 33.0 CALLS STOCK CALLED
- Herb: $AMRN. Co issues guidance for FY19 (Dec), sees FY19 (Dec) revs at or slightly above upper end of prior guidance of $410-425 mln vs. $420.78 mln S&P Capital IQ Consensus. Amarin is increasing its United States sales force to 800 sales representatives, up from 400 in most of 2019. Health professional targets will be expanded from approximately 50,000 to a planned 75,000 physicians along with planned increased frequency in the number of calls to these targets. Co issues in-line guidance for FY20 (Dec), sees FY20 (Dec) revs of $650-700 mln vs. $697.42 mln S&P Capital IQ Consensus. Beyond 2020, Amarin reiterates that it believes that VASCEPA total net revenue will grow to reach multiple billions of dollars. The history of other therapies for chronic conditions suggests that growth builds over multiple years. At this time, the company is not providing guidance regarding annual revenue levels beyond 2020.
- GOOSE: A TRADE: $AMRN BTC 22.5 CALLS @.05
- GOOSE: TRADES: $LK BTC 1/10/20 40.0 & 41.0 CALLS, @.10 & .15 $NTNX BTO STOCK @33.01 $NTNX STO 1/10/20 33.0 CALLS @.75 $AMRN STO 1/17/20 22.0 CALLS @.60 $LK BTO STOCK @34.00 Small marker
- GOOSE: TRADES: $AMRN BTC 1/3/20 22.0 CALLS @.02 $AMRN STO 1/17/20 20.5 PUTS @.88
- GOOSE: A TRADE: $AMRN BTO STOCK @20.97 Just rounding out my lot and to sell calls against it.
- GOOSE: TRADES: $LK STOCK @37.42 & 36.80 $AMRN STO 1/10/19 22.0 CALLS @.54 $STNE BTO STOCK 38.18
- GOOSE: TRADES: $AMRN STO 1/3/19 21.0 PUTS @.54 Strangling with existing calls. $LK BTO STOCK @35.63 Ran a little just after I bought.
- GOOSE: TRADES: $AMRN STO 1/3/19 22.0 CALLS @.70 $LK STO 1/3/19 35.0 CALLS @1.05 ITM already. ;>( covered call $LK STO 12/27/19 36.0 CALLS @.45 $LK BTO STOCK @34.14 & 35.12
- Herb: @GOOSE $AMRN Is the short call your only AMRN position?
- GOOSE: TRADES: $LK BTO STOCK 32.24 $AMRN BTO STOCK 21.44 $STNE BTO STOCK 38.10 Kept all purchases smallish. $HIIQ STO 1/17/19 21.0 CALLS @1.75 $LK STO 12/27/19 33.0 CALLS @.60 Covered
- Herb: $AMRN bot a little at 20.58. 20.55 was a measured move target.
- GOOSE: A TRADE: $AMRN STO 12/20/19 21.5 NTM CALLS @.44
- GOOSE: A TRADE: To cover $AMRN BTO STOCK 21.46 To cover my short 21.5 calls.
- issues: Bought small positions in these biotechs: $BDSI $JNCE (flag/phase 2 pattern) $PFNX $AKBA $HZNP $NK $APTO $AMRN. Also added to $DTIL.
- Herb: $AMRN. May not see patent trial decision till March so lot of traders bailing . Analysts give AMRN 85 % chance of winning but state that the generic Dr Reddy usually won’t settle as all they are risking is their legal fees.
- Herb: $AMRN. Friday after hrs they upped their 2020 guidance. Monday is start of generic settlement conference as well.
- WebstreamDyn: Interested in seeing what happens with $AMRN today. So far not moving from Friday night close. Lots of sellers in the first half hour this morning. I am out of my office all day so no buying / selling.
- tcburke82: $AMRN analysis raises the price target and then tells everyone to sell and I was only worried about a secondary. Gotta love the stock market.
- baronp0329: $AMRN, STC 85% position at 25.75, 13.4% profit. $LYFT, Nice move today with above avg volume, starter position 47.75. also new day /swing Dec 49 Calls. $ROKU, nice move from LOD & S1 129 with volume. New 1/2 position at 129.50, now at 137.60 $LK, added, now full position. $BIDU, new position at 121.70, Also long Dec 122 Calls.
- bsafriet: $AMRN $AXSM Haven’t been home today till now, wife had a procedure this morning - all is well. $AMRN saw the pop in $AMRN and wasn’t able to take profits - pop faded before I could make a trade. Would have been weird pulling over into the the breakdown lane to use my phone to enter the trade. Oh well....... $AXSM Had a 1/4 position. This one is a lottery ticket. Backed up the truck and sold 3/4 of position - kachingi!!!! I’ll hold the remaining shares in case there is a little more juice to squeeze out of the trade. Nice birthday present! Did wonderful things for my account balance as well!
- yongli: @bsafriet $AMRN $AXSM It is all gamble. small
- baronp0329: @bsafriet $AMRN $AXSM Good to hear your wife's procedure went well. And nice trade on AXSM. I had a GTC at 25.75 for 3/4 position that was hit this morning for a decent profit 13%.
- Herb: $AMRN. from my friend: I listened to CC Ceo very against selling co to big Pharma. Wants to grow Co himself ... so now concern over slow slog to train reps to sell drug. No direct to consumer ads till mid 2020. Next catalyst is the results of the patent challenge
- Herb: $AMRN. Generic co trying to carve out part of Amarins IP. Amarin has patents for everything except first 90 days of use. Dr Reddy wants right to sell Vascepa for less than 90 days of treatment.
- issues: @Herb $MIRM Thank you for this addition to my list of the best biotechs: $AUPH $DCPH $ISEE $JNCE $HZNP $AMRN $PFNX $AKBA... we hold AUPH ISEE and others not listed.
- Mpower27: @Herb $AMRN Your friend have any insight into the CEO, as in has he done this sort of thing before?
- Herb: @Mpower27 $AMRN Ceo is an accountant but has been involved with biotechs before. The key guy now is their attorney and how defensible the patents are.
- tcburke82: $AMRN So what are members thinking? Sell the pop or hold.
- PhilHarmonic: @tcburke82 $AMRN It's having trouble getting through that particular resistance. It's been trying for a whole year. So it exciting to see if it can continue through to a new level.
- Henry: @tcburke82 $AMRN No position but these drugs stocks have been rocketing much higher than they used to. The stock didn't reopen for trading until the regular market hours had been closed 90 minutes. Given what's happened with other drug approvals, I expect it to move higher at the open.
- tcburke82: @Henry $AMRN I watched it thru the AH’s and it appeared the sellers ran out around 7pm and it ran hard until 8pm. I agree I think it goes higher after the first hour.
- GOOSE: A TRADE: $AMRN BTO STOCK @23.53 An add.
| Stock Price | $0.44 |
| Change | -3.59% |
| Volume | 873,605 |
Amarin Corporation PLC is a biopharmaceutical company that commercializes and develops therapeutics to improve cardiovascular health.
Request Video of AMRNAlready a member? Sign in here.
Past Month
Leading Peers
-
$20.45 36.33%
-
$21.82 26.20%
-
$10.86 11.30%
Past Month
Lagging Peers
-
$6.36 -27.48%
-
$33.89 -25.10%
-
$10.84 -18.09%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!